Credentials:

American Board of Internal Medicine – Internal Medicine and Rheumatology

MD - SUNY Upstate Medical Center, Syracuse N.Y. 1998

MPH - George Washington University 2006

Affiliation:

Assistant Professor - Georgetown University

BIO:

Brian Walitt MD MPH is an assistant professor of medicine at Georgetown University. His research interest is fibromyalgia and associated autoperceptual disorders where he is both published and funded.

Dr. Walitt has received several intramural and pharmaceutical research grants in the areas of fibromyalgia. He was selected as a Centocor Health Outcomes in Rheumatic Disease fellow. He was awarded an American College of Rheumatology Research and Education Foundation Clinical Investigator Fellowship Award for his work with postmenopausal hormone therapy in rheumatic disease. He is currently a co-investigator in the Women’s Health Initiative and an active investigator for the Cochrane review. He is a member of the OMERACT fibromyalgia committee. He has performed several investigator-initiated studies in fibromyalgia using neuroimaging techniques and neuropsychological instruments. He is also actively involved with pharmaceutical trials for the treatment of fibromyalgia. He was most recently awarded the American College of Rheumatology Investigator Award for his study entitled ‘The effects of exercise therapy on brain function in fibromyalgia’.

Recent NDB research Recent NDB research

Wolfe F, Walitt BT, Katz RS, Häuser W. Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One. 2014 14;9(2):e88740. PubMed link
Wolfe F, Walitt BT, Katz RS, Häuser W. Social security work disability and its predictors in patients with fibromyalgia. Arthritis Care Res (Hoboken). 2014 Feb 10. doi: 10.1002/acr.22305. PubMed link
Wolfe F, Michaud K, Busch RE, Katz RS, Rasker JJ, Shahouri SH, Shaver TS, Wang S, Walitt BT, Häuser W. Polysymptomatic Distress in Patients with Rheumatoid Arthritis: Understanding disproportionate response and its spectrum. Arthritis Care Res (Hoboken). 2014 Feb 4. doi: 10.1002/acr.22300. PubMed link
Wolfe F, Michaud K, Busch RE, Katz RS, Rasker JJ, Shahouri SH, Shaver TS, Wang S, Walitt BT, Häuser W. Polysymptomatic Distress in Patients with Rheumatoid Arthritis: Understanding disproportionate response and its spectrum. Arthritis Care Res (Hoboken). 2014 Feb 4. doi: 10.1002/acr.22300. PubMed link
Wolfe F, Walitt BT, Häuser W. What is fibromyalgia, how is it diagnosed and what does it really mean? Arthritis Care and Research. 2013: doi: 10.1002 PubMed link
Wolfe F, Walitt B. Culture, science and the changing nature of fibromyalgia. Nature Reviews Rheumatology. 2013:doi: 10.1038 PubMed link
Wolfe F, Walitt BT, Katz RS, Lee YC, Michaud KD, Häuser W. Longitudinal Patterns of Analgesic and Central Acting Drug Use and Associated Effectiveness in Fibromyalgia. European Journal of Pain. 2013:(4):581-6. PubMed link
Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Häuser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011; 38(10):2238-46. PubMed link
Wolfe F, Hassett AL, Katz RS, Michaud K, Walitt B. Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice.J Rheumatol. 2011 Jun;38(6):1104-12. doi: 10.3899/jrheum.100511. PubMed link
Wolfe F, Häuser W, Hassett AL, Katz RS, Walitt BT. The development of fibromyalgia--I: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain. 2011 Feb;152(2):291-9. doi: 10.1016/j.pain.2010.09.027. PubMed link